Corporations
Tessaract Bio-Systems
Biotech and augmentation firm
// Where You Stand
// On Record
Leader
Dr. Sera Ondine, Chief Science Officer (the Board is technically in charge; Ondine ignores them)
Structure
Flat research culture on paper; in practice, Ondine's lab teams operate autonomously and report only to her. Corporate governance exists to keep investors calm.
Goals
Develop and sell biological augmentations, genetic therapies, and psi-amplification treatments. Their real ambition: crack the biological basis of Drift-sensitivity and commercialize it.
Philosophy
The body is unfinished. Evolution abandoned us at the threshold of something greater. They will complete the work -- for a fee.
Limits
Ondine refuses to deploy biological weapons or design pathogens for warfare. Her research has caused accidental deaths in the dozens -- but deliberate mass death is a line she has never crossed and claims she never will.
Rivals
- The Pale Covenantviews their work as abomination
- Remnant Senate regulatorsif they ever get jurisdiction back
- A rival firm called Omensward they drove into bankruptcy and who now wants blood
// Referenced In
No references recorded yet.